Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM183A pseudogene 2 (TMEM183AP2) is a processed pseudogene that resembles the parental gene TMEM183A but does not encode a functional protein product[3][5][6]. Pseudogenes like TMEM183AP2 often arise through gene duplication or retrotransposition events, resulting in DNA segments that are homologous to known protein-coding genes but lack the ability to produce functional protein due to mutations or missing regulatory elements[6]. While most pseudogenes do not produce functional products or have direct biological roles, some can exert regulatory effects on gene expression at the RNA level in rare instances, but such roles have not been described for TMEM183AP2[6]. TMEM183AP2 is not considered a therapeutic target, nor is there evidence of disease relevance, drug interactions, or biomarker potential[3][5][6]. In summary, TMEM183A pseudogene 2 is a non-coding pseudogene with no known protein function, disease association, or druggability and is not a receptor, enzyme, transporter, or conventional molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM183A pseudogene 2 (TMEM183AP2).